1063 related articles for article (PubMed ID: 16951472)
1. [Anabolic treatment for osteoporosis: PTH treatment].
Kaji H; Sugimoto T
Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
[TBL] [Abstract][Full Text] [Related]
2. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
Wada S; Fukawa T; Kamiya S
Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
[TBL] [Abstract][Full Text] [Related]
5. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT; Christensen PM; Ejersted C; Langdahl BL
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
[TBL] [Abstract][Full Text] [Related]
6. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis.
Garcés C; García LE
Maturitas; 2006 Apr; 54(1):47-54. PubMed ID: 16257150
[TBL] [Abstract][Full Text] [Related]
7. [Up-to-date treatments for osteoporosis].
Bors K
Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis: strategies for prevention and management.
Keen R
Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):109-22. PubMed ID: 17350547
[TBL] [Abstract][Full Text] [Related]
9. Treatment of osteoporosis: all the questions we still cannot answer.
Laroche M
Am J Med; 2008 Sep; 121(9):744-7. PubMed ID: 18724959
[TBL] [Abstract][Full Text] [Related]
10. [Who are the candidates for the treatment by raloxifen ?].
Hagino H
Clin Calcium; 2004 Oct; 14(10):111-3. PubMed ID: 15577141
[TBL] [Abstract][Full Text] [Related]
11. A review of combination regimens for osteoporosis--prevention and treatment.
Miller E; Kalin MF
Int J Fertil Womens Med; 2002; 47(5):198-204. PubMed ID: 12469706
[TBL] [Abstract][Full Text] [Related]
12. Strontium ranelate for osteoporosis?
Drug Ther Bull; 2006 Apr; 44(4):29-32. PubMed ID: 16617933
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic options in osteoporosis.
Dominguez LJ; Scalisi R; Barbagallo M
Acta Biomed; 2010; 81 Suppl 1():55-65. PubMed ID: 20518192
[TBL] [Abstract][Full Text] [Related]
15. [Absolute risk for fracture and WHO guideline. Pharmacological intervention to prevent osteoporotic fractures in the elderly].
Hosoi T;
Clin Calcium; 2007 Jul; 17(7):1098-104. PubMed ID: 17607078
[TBL] [Abstract][Full Text] [Related]
16. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.
Anastasilakis AD; Polyzos SA; Avramidis A; Papatheodorou A; Terpos E
Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890
[TBL] [Abstract][Full Text] [Related]
17. Continuous broad protection against osteoporotic fractures with strontium ranelate.
Ferrari S
Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv20-4. PubMed ID: 19783590
[TBL] [Abstract][Full Text] [Related]
18. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
Epstein S
Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
[TBL] [Abstract][Full Text] [Related]
19. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
Neuprez A; Hiligsmann M; Scholtissen S; Bruyere O; Reginster JY
Adv Ther; 2008 Dec; 25(12):1235-56. PubMed ID: 19066755
[TBL] [Abstract][Full Text] [Related]
20. [Drug treatment for the treatment of primary osteoporosis].
Halbekath J
Z Arztl Fortbild Qualitatssich; 2000 Aug; 94(6):453-60. PubMed ID: 10996934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]